Third-generation α 1-adrenergic antagonists are pharmacologically uroselective in that they are competitive antagonists for prostatic α 1A-receptors. [16,17] Blockade of these receptors relaxes ...

The model was constructed not only to calculate the economic consequences of treatment with both drugs, but also to extrapolate outcomes over time and to derive effectiveness outcomes that extend ...